Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
18.03.24
-
18.03.25
2.26%
30.03.24

Could be worthwhile Investment >10% per year
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
17.03.24
€0.30
30.11.25
76.96%
28.03.24

Could be very worthwhile Investment >20% year
buy
Inventiva SA

Start price
Target price
Perf. (%)
€3.71
17.03.24
€5.00
31.01.26
-2.70%
19.03.24

Could be very worthwhile Investment >20% year
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€10.20
17.03.24
€16.00
30.06.26
-8.82%
19.03.24

Could be very worthwhile Investment >20% year
buy
PNE AG

Start price
Target price
Perf. (%)
€13.94
16.03.24
€20.00
16.04.24
-5.02%
17.04.24

Could be worthwhile Investment >10% per year
BICO Group AB

Start price
Target price
Perf. (%)
€3.74
16.03.24
€1.00
16.03.25
9.03%
30.03.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
16.03.24
€2.00
16.03.25
2.26%
30.03.24

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
buy
Chromadex Corp

Start price
Target price
Perf. (%)
€2.22
16.03.24
€4.00
16.03.25
53.15%
30.03.24

EBIT decline/stagnation expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€4.89
16.03.24
€48.00
16.03.25
-12.06%
30.03.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
buy
Deutsche Pfandbriefbank AG

Start price
Target price
Perf. (%)
€4.53
16.03.24
€5.00
16.03.25
6.18%
27.03.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Northern Data AG

Start price
Target price
Perf. (%)
€26.90
16.03.24
€66.00
16.03.25
-0.56%
30.03.24

Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Standard Investments for future growth
High dividend yield expected
buy
Geron Corp.

Start price
Target price
Perf. (%)
€1.68
12.03.24
-
12.03.25
81.49%
15.03.24

Could be very worthwhile Investment >20% year
buy
SoftBank Group

Start price
Target price
Perf. (%)
€52.31
12.03.24
-
12.03.25
1.95%
02.06.24

buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€64.50
08.03.24
-
08.03.25
-8.53%
15.03.24

Could be worthwhile Investment >10% per year
buy
Deutsche Rohstoff AG

Start price
Target price
Perf. (%)
€34.70
08.03.24
€35.00
08.03.25
6.92%
05.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Rising EBIT margin expected
Fair valuation
buy
Microstrateg.a New

Start price
Target price
Perf. (%)
€1,181.0
08.03.24
-
08.04.24
18.37%
09.04.24

Could be worthwhile Investment >10% per year
buy
flatexDEGIRO AG

Start price
Target price
Perf. (%)
€9.56
07.03.24
€10.00
07.03.25
2.85%
14.03.24

EBIT growth > 30% per year expected
Known brand
Future proof or reliable business model
Higher EBIT margin than peer group
buy
flatexDEGIRO AG

Start price
Target price
Perf. (%)
€9.63
07.03.24
-
07.03.25
38.21%
02.07.24

buy
Harmony Gold Mining

Start price
Target price
Perf. (%)
€6.32
06.03.24
€11.00
06.03.25
8.86%
16.03.24

EBIT growth >5% per year expected
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
buy
Silvercorp Metals Inc.

Start price
Target price
Perf. (%)
€2.42
06.03.24
€3.00
06.03.25
7.84%
16.03.24

Could be worthwhile Investment >10% per year
Capable Management
Revenue growth >5% per year expected
positive Cash Flow expected
buy
U.S. Gold Corp.

Start price
Target price
Perf. (%)
€3.33
06.03.24
€5.00
06.03.25
3.30%
16.03.24

Higher EBIT margin than peer group
High dividend yield expected
Good rating
EBIT growth >5% per year expected
buy
Helma Eigenheimbau AG

Start price
Target price
Perf. (%)
€0.66
04.03.24
-
04.03.25
-59.55%
16.03.24

Could be worthwhile Investment >10% per year
Good culture
Below average Management
Super Micro Computer

Start price
Target price
Perf. (%)
€1,044.5
04.03.24
-
04.03.25
-3.73%
16.03.24

Capable Management
Probably not worthwhile Investment
Few uniques
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€25.60
04.03.24
-
04.03.25
-0.78%
15.03.24

Risky Investment
Vanda Pharmaceuticals

Start price
Target price
Perf. (%)
€4.00
04.03.24
-
04.03.25
-13.00%
16.03.24

Probably not worthwhile Investment